Utvidet returrett til 31. januar 2025

Cancer and Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America

av Feldman
Om Cancer and Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America

This issue of Rheumatic Disease Clinics, guest edited by Dr. John Davis, will discuss Cancer and Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: rheumatic drugs and malignancy potential, biologic drugs and cancer, methotrexate and cancer, managing rheumatoid arthritis with cancer, Sjogren''s Syndrome and cancer, lupus and cancer, scleroderma and cancer, cancer and spondylarthritis, and cancer immunotherapy.

Vis mer
  • Språk:
  • Engelsk
  • ISBN:
  • 9780323761260
  • Bindende:
  • Hardback
  • Sider:
  • 240
  • Utgitt:
  • 10. juli 2020
  • Dimensjoner:
  • 152x229x0 mm.
  • Vekt:
  • 480 g.
  • BLACK NOVEMBER
  Gratis frakt
Leveringstid: 2-4 uker
Forventet levering: 8. desember 2024

Beskrivelse av Cancer and Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America

This issue of Rheumatic Disease Clinics, guest edited by Dr. John Davis, will discuss Cancer and Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: rheumatic drugs and malignancy potential, biologic drugs and cancer, methotrexate and cancer, managing rheumatoid arthritis with cancer, Sjogren''s Syndrome and cancer, lupus and cancer, scleroderma and cancer, cancer and spondylarthritis, and cancer immunotherapy.

Brukervurderinger av Cancer and Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America



Finn lignende bøker
Boken Cancer and Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America finnes i følgende kategorier:

Gjør som tusenvis av andre bokelskere

Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.